ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Elevated Tissue Factor and TFPI Levels in Acute COPD Exacerbations: A Prospective Comparison With Stable COPD and Healthy Controls.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PurposeThis prospective study aimed to evaluate tissue factor (TF) and tissue factor pathway inhibitor (TFPI) as potential biomarkers of hypercoagulability in patients with acute exacerbation of COPD (AECOPD), compared to stable COPD patients and healthy controls.Patients and methods30 patients with AECOPD, 30 stable COPD patients, and 30 healthy controls were enrolled from April 2021 to September 2022 at the Department of Respiratory Medicine and Critical Care Medicine, Wusong Central Hospital in Baoshan District, Shanghai, China. Clinical data, serum levels of TF, TFPI, inflammatory markers, and coagulation parameters were collected. Pearson correlation analysis was performed to examine the relationships between TF, TFPI, inflammatory markers, and components of the coagulation-fibrinolysis system in patients with AECOPD.ResultsSerum levels of TF, TFPI, C-reactive protein, interleukin-8, and tumor necrosis factor-alpha were significantly elevated in the acute exacerbation group compared to both the stable and control groups (p < 0.05). No significant differences in D-dimer and prothrombin time were observed between the acute exacerbation and stable groups. In AECOPD patients, IL-8 was negatively correlated with FEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.